Literature DB >> 2379321

Specificities of IgM and IgG anti-histone H1 autoantibodies in autoimmune mice.

M Monestier1, T M Fasy, M E Debbas, L Bohm.   

Abstract

Autoantibodies to histone H1 represent the most common specificity among anti-histone autoantibodies in systemic autoimmune diseases. Here we analyse anti-H1 autoantibodies in mice from the following autoimmune strains: MRL/Mp-lpr/lpr, NZB and NZB x NZW/F1. Autoantibodies of the IgM isotype bind predominantly to epitopes located in the COOH-terminal domain of the H1 molecule, whereas IgG autoantibodies in the MRL/Mp-lpr/lpr and NZB strains also recognize epitopes requiring the integrity of both the COOH-terminal and the central globular domains of H1. In both of these strains, the titre of these IgG anti-H1 antibodies rises during the course of the disease. The importance of three-dimensional structure of histone H1 was attested by a significant decrease in IgG binding after cleavage of the H1 molecule within the folded globular domain. The binding of these sera to H1 variants from various species was also investigated and a strong binding of MRL/Mp-lpr/lpr sera to certain phylogenetically distant histone H1 variant molecules (sea-urchin sperm H1 and chicken erythrocyte H5) was observed. This cross-reacting binding can be explained by the presence in MRL/Mp-lpr/lpr sera of autoantibodies to H1(0), a variant found in non-dividing cells and exhibiting sequence homologies to the above mentioned variants. The significance and the possible implications of these data for the pathogenesis of autoimmunity are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379321      PMCID: PMC1535026          DOI: 10.1111/j.1365-2249.1990.tb05288.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Monoclonal anti-histone H1 autoantibodies from MRL lpr/lpr mice.

Authors:  M Monestier; T M Fasy; L Böhm
Journal:  Mol Immunol       Date:  1989-08       Impact factor: 4.407

2.  Studies on the role and mode of operation of the very-lysine-rich histone H1 in eukaryote chromatin. The three structural regions of the histone H1 molecule.

Authors:  P G Hartman; G E Chapman; T Moss; E M Bradbury
Journal:  Eur J Biochem       Date:  1977-07-01

3.  Studies on histones. 7. Preparative methods for histone fractions from calf thymus.

Authors:  E W Johns
Journal:  Biochem J       Date:  1964-07       Impact factor: 3.857

4.  Antibody against globular domain of H10 histone.

Authors:  H Yasuda; K A Logan; E M Bradbury
Journal:  FEBS Lett       Date:  1984-01-30       Impact factor: 4.124

5.  A theoretical consideration of the lysine-rich histones: H1 from a mammal and an echinoderm, H5 from erythrocytes.

Authors:  P D van Helden
Journal:  J Theor Biol       Date:  1982-06-07       Impact factor: 2.691

6.  Isolation and characterisation of subfractions of nuclear protein H1 degree.

Authors:  B J Smith; E W Johns
Journal:  FEBS Lett       Date:  1980-01-28       Impact factor: 4.124

7.  Histone H10 accumulates in growth-inhibited cultured cells.

Authors:  J Pehrson; R D Cole
Journal:  Nature       Date:  1980-05-01       Impact factor: 49.962

8.  The structure of histone H1 and its location in chromatin.

Authors:  J Allan; P G Hartman; C Crane-Robinson; F X Aviles
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

9.  In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.

Authors:  M Gioud; B L Kotzin; R L Rubin; F G Joslin; E M Tan
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.